The company’s upsized offering is a hopeful sign for venture investors in the sector.

Ceribell Inc. launched its initial public offering of more than 10.6 million shares of common stock at $17 and steadily saw ...

Ceribell shares were higher in their Nasdaq debut after an upsized initial public offering priced at the high end of a projected range. Shares of Ceribell, maker of an AI-powered brain monitoring ...

Upstream Bio (UPB) shares rallied 32% Friday following the asthma drug developer’s $255M upsized initial public offering. Read more here.

Three US life-sciences companies hitting the market delivered mostly robust early trading after investors strongly supported ...

CeriBell (NASDAQ:CBLL) shares rallied 35% Friday following the medical device maker’s $180M initial public offering. Shares ...

Ceribell Inc., a medical-device maker that uses artificial intelligence to monitor patient seizures, was on track for a ...

Shares of Upstream Bio opened 26.5% above the initial public offering price in their Nasdaq debut on Friday, valuing the drug developer at $1.05 billion.

CeriBell announced that it priced an upsized initial public offering (IPO), expecting proceeds of approximately $180.3 ...

The average IG bond spread edged in by 1bp to 84bp, a record post financial crisis low, on Thursday, and the HY bond spread gapped out by 5bp to 299bp, according to ICE BofA data.